Senescence and cytokines modulate the NK cell expression

被引:55
作者
Krishnaraj, R
机构
[1] Geriatric Medicine (M/C 787), Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612
关键词
natural killer cells; phenotype; cytotoxicity; cytokines; cancer; interferon gamma; IL-2; lymphocytes; N-CAM (CD56);
D O I
10.1016/S0047-6374(97)00045-6
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have been investigating senescence-related changes in human peripheral blood natural killer (NK2) cells. Data accumulated so far consistently and clearly show that both basal and cytokine (IL-2 and interferon alpha and gamma) induced antitumor MHC-unrestricted cytotoxic activity of NK cells are well-preserved in the healthy elderly. To investigate if the non-cytotoxic functions of NK cells are also spared from the influence of senescence, recombinant IL-2-inducible secretion of IFN-gamma, which serves as a first line of defense, was examined. The amount of IFN-gamma secreted by purified, 18 h activated NK cells from the elderly was only 25 percent of that released by the cells from the young. Thus, the type 1 cytokine-inducible cytotoxic and cytokine secretory functions appear to be dissociable properties of NK cells, at least in the elderly. However, this aging-related early phase secretory deficit could be overcome by chronic stimulation with IL-2 (7 day culture). Since different subsets could perform different functions, we analyzed the NK subsets by flow cytometry. A minor CD56(bright) subset and a major CD56(dim) subset could be distinguished based on the density of expression of the cell surface CD56 molecule (N-CAM). We inquired If immunosenescence is likely to impact the steady-state level of circulating NK subsets. A significant decrease (P < 0.01) in percent CD56(bright) among CD56(+) cells was observed in the elderly with a relative sparing of the CD56(dim) subset. The CD56(bright)/CD56(dim) ratio, perhaps representing NK cell maturity status, declined with age. This maturation-related subset redistribution and partial loss during aging of high affinity IL-2 alpha beta gamma receptor bearing 'immature' CD56(bright) NK cells has not been reported before. It could be a consequence of the decline in the level of IL-2 during aging. It is concluded that post-adolescent age-associated modulations in human NK cells are not expressed uniformly; they are pronounced in some, subtle in others but negligible in yet other biological parameters. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:89 / 101
页数:13
相关论文
共 40 条
[1]   INCREASED KILLER CELL-ACTIVITY IN AGED HUMANS [J].
BATORY, G ;
BENCZUR, M ;
VARGA, M ;
GARAM, T ;
ONODY, C ;
PETRANYI, GG .
IMMUNOBIOLOGY, 1981, 158 (05) :393-402
[2]  
BAUM LL, 1993, IMMUNOL ALLERGY CLIN, V13, P535
[3]  
Bhooma Thanikachalam, 1994, Aging Immunology and Infectious Disease, V5, P83
[4]   FUNCTIONAL CONSEQUENCES OF INTERLEUKIN-2 RECEPTOR EXPRESSION ON RESTING HUMAN-LYMPHOCYTES - IDENTIFICATION OF A NOVEL NATURAL-KILLER-CELL SUBSET WITH HIGH-AFFINITY RECEPTORS [J].
CALIGIURI, MA ;
ZMUIDZINAS, A ;
MANLEY, TJ ;
LEVINE, H ;
SMITH, KA ;
RITZ, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (05) :1509-1526
[5]   IMMUNOLOGICAL STUDIES OF AGING - DECREASED PRODUCTION OF AND RESPONSE TO T-CELL GROWTH-FACTOR BY LYMPHOCYTES FROM AGED HUMANS [J].
GILLIS, S ;
KOZAK, R ;
DURANTE, M ;
WEKSLER, ME .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 67 (04) :937-942
[6]  
HERBERMAN RB, 1989, NAT IMMUN, P171
[7]  
KAY MB, 1976, CLIN IMMUNOL, V6, P268
[8]   AGING - CHANGES IN CARDIAC ALPHA-1-ADRENOCEPTOR RESPONSIVENESS AND EXPRESSION [J].
KIMBALL, KA ;
CORNETT, LE ;
SEIFEN, E ;
KENNEDY, RH .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1991, 208 (03) :231-238
[9]   AGE-ASSOCIATED ALTERATIONS IN HUMAN NATURAL-KILLER CELLS .2. INCREASED FREQUENCY OF SELECTIVE NK SUBSETS [J].
KRISHNARAJ, R ;
BLANDFORD, G .
CELLULAR IMMUNOLOGY, 1988, 114 (01) :137-148
[10]   AGE-ASSOCIATED ALTERATIONS IN HUMAN NATURAL-KILLER-CELLS .1. INCREASED ACTIVITY AS PER CONVENTIONAL AND KINETIC-ANALYSIS [J].
KRISHNARAJ, R ;
BLANDFORD, G .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1987, 45 (02) :268-285